2018-11-06 09:28 ET - News Release

Mr. Boris Ziger reports

MATICA AND YUNIFY DEVELOP FIRST NEW CONSUMER PRODUCT

Matica Enterprises Inc. and Yunify Natural Technologies have developed their first unique and proprietary product for the consumer market.

One of the challenges facing both medical and recreational users alike is the odour of cannabis after smoking of the product. Matica and Yunify have developed a spray that captures odours through Yunify's natural ions encapsulation technology; odours are trapped and they are neutralized. After spraying an area, the odour disappears and the sprayed area is left clean and fresh smelling. The product can be used as a personal spray and is also being developed as a room deodorizer. The company is working to quickly bring the product into the consumer marketplace. As the company approaches a product launch date, Matica will be posting on the company website as to where the product will be available for purchase. Interested retailers should contact the company directly.

Matica Enterprises chief executive officer Boris Ziger states: "Medical users, who need to smoke cannabis throughout the day, can now do so without worrying about the odour. This product is a game changer. Cannabis smokers can now go about their lives without worry. This spray can be used personally and the user will only smell pleasant and fresh. For those who smoke at home, their rooms can now smell clean and fresh."

Yunify chief executive officer Stephan Doyon informs: "This personal care grade mist is the first product resulting from our collaboration with Matica. This new product utilizes naturally programmed ion encapsulation technology, and contains naturally balanced minerals and trace minerals with high ionic exchange ability. It is a natural and green product. Our team at Yunify is busy working on more solutions and more innovative new products. There is much more coming down the product pipeline."

About Matica Enterprises Inc.

Matica Enterprises has an agreement to earn 70 per cent of RoyalMax Biotechnology Canada Inc. RoyalMax Biotechnology Canada has submitted the confirmation of readiness for a licence under Access to Cannabis for Medical Purposes Regulations to Health Canada for the fully completed 10,000-square-foot production facility in Dorval. The company is also committed to building one million square feet of greenhouses in the township of Hemmingford, south of Montreal. Matica Enterprises has also entered into an agreement to acquire a 40-per-cent position in Yunify Natural Technologies, a Quebec-based health and personal care research and innovation company.

We seek Safe Harbor.